Pneumococcal 7-valent conjugate vaccine (Pfizer)

肺炎球菌7价共轭疫苗（辉瑞）

Report date: 2024/12/31 20:00:06

Base Information

Drug NamePneumococcal 7-valent conjugate vaccine (Pfizer)
Drug Alias NamePrevenar 7Prevnar
ClassificationVaccines > Development/production technology > Conjugated vaccineVaccines > Biological material > Bacterial vaccineVaccines > Application > Prophylactic vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsOtitis MediaUrinary Bladder NeoplasmsColonic Neoplasms +[7] 
Global Approved IndicationsOtitis MediaPneumonia, BacterialPneumococcal Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2000/02/17
Country/TerritoryCzechiaBelgiumUnited States +[11] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesSinovac Life Sciences Co Ltd
Inactive CompaniesWyeth LlcGerman-Jordanian UniversityPfizer Ltd +[8] 
Active IndicationsOtitis MediaPneumonia, BacterialPneumococcal Infections
Inactive IndicationsUrinary Bladder NeoplasmsColonic NeoplasmsBreast Neoplasms +[4] 

Other Information

ATC CodeJ07AL02
Related LinksWikipedia